LSV Holds 5.48% Of GoodRx Class A Shares Without Seeking To Influence Control

The investment adviser's position accompanies GoodRx's push to put prescription savings information inside Google Cloud's healthcare tools.

Share
LSV Holds 5.48% Of GoodRx Class A Shares Without Seeking To Influence Control

LSV Asset Management reported a 5.48% stake in GoodRx, which helps Americans find cheaper prescriptions, in a passive ownership disclosure filed Tuesday. The investment adviser reported 5,868,895 Class A shares as of September 30, held without a purpose of changing or influencing the company's control.

Voting Power Covers Fewer Shares

LSV had sole authority to sell or otherwise dispose of its entire reported position, while its sole voting power covered 2,982,356 shares. It reported no shared voting or disposal authority.

The economic rights belong to LSV's clients, including funds and managed accounts: they can receive dividends and sale proceeds or direct where those payments go. LSV certified that it bought and holds the securities as part of its ordinary business activities.

Prescription Savings Inside Gemini

GoodRx separately announced a Google Cloud partnership Tuesday that brings its prescription pricing and savings information into Gemini for healthcare. Healthcare teams can compare prices across pharmacies and find drugmakers' self-pay programs within the platform.

GoodRx shares rose 4.7% in Tuesday premarket trading after the announcement. The company had a market value of $1.2 billion as of 2:38 p.m. ET Tuesday.

The partnership extends the reach of GoodRx's existing savings business. Consumers can compare nearby pharmacy prices free of charge, then present a code at the counter for a negotiated price. Pharmacy benefit managers and partner pharmacies pay GoodRx when consumers fill prescriptions using those codes.

GoodRx also sells Gold subscriptions, with lower prices, mail delivery and telehealth visits, and offers advertising and savings programs to drugmakers through its pharma direct business.

GoodRx chief technology officer Nitin Shingate described an ambition beyond the Google Cloud arrangement: "Starting with Google Cloud, our standards-based MCP integration creates a scalable foundation to expand GoodRx capabilities across the broader AI ecosystem."

Sources

More on GoodRx

All GoodRx (GDRX) coverage →